IL-10, IL-13, Eotaxin and IL-10/IL-6 ratio distinguish breast implant-associated anaplastic large-cell lymphoma from all types of benign late seromas
Open Access
- 4 November 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cancer Immunology, Immunotherapy
- Vol. 70 (5), 1379-1392
- https://doi.org/10.1007/s00262-020-02778-3
Abstract
Breast implant-associated anaplastic large-cell lymphoma (BI-ALCL) is an uncommon peripheral T cell lymphoma usually presenting as a delayed peri-implant effusion. Chronic inflammation elicited by the implant has been implicated in its pathogenesis. Infection or implant rupture may also be responsible for late seromas. Cytomorphological examination coupled with CD30 immunostaining and eventual T-cell clonality assessment are essential for BI-ALCL diagnosis. However, some benign effusions may also contain an oligo/monoclonal expansion of CD30 + cells that can make the diagnosis challenging. Since cytokines are key mediators of inflammation, we applied a multiplexed immuno-based assay to BI-ALCL seromas and to different types of reactive seromas to look for a potential diagnostic BI-ALCL-associated cytokine profile. We found that BI-ALCL is characterized by a Th2-type cytokine milieu associated with significant high levels of IL-10, IL-13 and Eotaxin which discriminate BI-ALCL from all types of reactive seroma. Moreover, we found a cutoff of IL10/IL-6 ratio of 0.104 is associated with specificity of 100% and sensitivity of 83% in recognizing BI-ALCL effusions. This study identifies promising biomarkers for initial screening of late seromas that can facilitate early diagnosis of BI-ALCL.Keywords
Funding Information
- Sapienza Università di Roma (Ateneo 2017)
- Associazione Italiana per la Ricerca sul Cancro (IG17009)
- LazioInnova (85-2017-13750)
- Ministero dell’Istruzione, dell’Università e della Ricerca (PRIN 2017)
- Aesthetic Surgery Education and Research Foundation (8580)
- Università degli Studi di Roma La Sapienza
This publication has 56 references indexed in Scilit:
- RNAscope: A Novel in Situ RNA Analysis Platform for Formalin-Fixed, Paraffin-Embedded TissuesThe Journal of Molecular Diagnostics, 2012
- Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL)Neuro-Oncology, 2011
- pROC: an open-source package for R and S+ to analyze and compare ROC curvesBMC Bioinformatics, 2011
- A Brief History of IL-9The Journal of Immunology, 2011
- IL-9 Production by Regulatory T Cells Recruits Mast Cells That Are Essential for Regulatory T Cell-Induced Immune SuppressionThe Journal of Immunology, 2011
- How are TH2-type immune responses initiated and amplified?Nature Reviews Immunology, 2010
- IL-9 induces differentiation of T H 17 cells and enhances function of FoxP3 + natural regulatory T cellsProceedings of the National Academy of Sciences of the United States of America, 2009
- Plasticity of CD4+ FoxP3+ T cellsCurrent Opinion in Immunology, 2009
- Autocrine release of interleukin-9 promotes Jak3-dependent survival of ALK+ anaplastic large-cell lymphoma cellsBlood, 2006
- Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray ExperimentsStatistical Applications in Genetics and Molecular Biology, 2004